• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-146a 和肿瘤坏死因子受体相关因子 6(TRAF6)在重症肌无力患者血清中的表达及临床意义。

Expression and Clinical Significance of miR-146a and Tumor Necrosis Factor Receptor-Associated Factor 6 (TRAF6) in Myasthenia Gravis Patient Serum.

机构信息

Department of General Medicine, Foshan First People's Hospital, Foshan City, Guangdong Province, 528000, China.

Department of Infectious Disease, Foshan First People's Hospital, Foshan City, Guangdong Province, 528000, China.

出版信息

Biomed Res Int. 2021 Apr 20;2021:5573469. doi: 10.1155/2021/5573469. eCollection 2021.

DOI:10.1155/2021/5573469
PMID:33997016
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8081603/
Abstract

OBJECTIVE

To investigate the expression and clinical significance of miR-146a and tumor necrosis factor receptor-associated factor 6 (TRAF6) in myasthenia gravis (MG) patient serum.

METHODS

The serum of 52 patients with MG and 60 healthy individuals was collected in our hospital. The expression of miR-146a and TRAF6 in serum was measured by real-time PCR (RT-PCR). Comparison among serum miR-146a and TRAF6 mRNA group clinical characteristics and assorted expressions was done with the correlation among the two groups evaluated. Logistics regression was used to analyze the effect of miR-146a and TRAF6 mRNA on MG development with the ROC curve applied for an investigation into the diagnostic role of miR-146a and TRAF6 mRNA expression in MG development.

RESULTS

miR-146a and TRAF6 mRNA were significantly increased in the patients with MG compared with the healthy controls. Significant differences were identified in respiratory muscle endurance, muscle weakness level, vital capacity, and maximal voluntary ventilation between the two groups. Additionally, correlation analysis has discovered a positive correlation between miR-146a and TRAF mRNA expression in patients with MG. miR-146a and TRAF6 mRNA are independent MG occurrence factors exhibited by multivariate analysis while areas under ROC curve (AUCs) of miR-146a and TRAF6 mRNA in MG diagnosis were established by ROC curve analysis with results being 0.782 and 0.703, correspondingly.

CONCLUSION

miR-146a and TRAF6 mRNA are highly expressed in MG patients and can affect MG occurrence. miR-146a is a suitable candidate marker for diagnosing MG.

摘要

目的

研究 miR-146a 和肿瘤坏死因子受体相关因子 6(TRAF6)在重症肌无力(MG)患者血清中的表达及其临床意义。

方法

收集我院 52 例 MG 患者和 60 例健康个体的血清。采用实时 PCR(RT-PCR)检测血清中 miR-146a 和 TRAF6 的表达。比较两组血清 miR-146a 和 TRAF6mRNA 组的临床特征和表达情况,评估两组之间的相关性。采用逻辑回归分析 miR-146a 和 TRAF6mRNA 对 MG 发病的影响,ROC 曲线分析 miR-146a 和 TRAF6mRNA 表达在 MG 发病中的诊断作用。

结果

与健康对照组相比,MG 患者的 miR-146a 和 TRAF6mRNA 显著升高。两组间呼吸肌耐力、肌无力程度、肺活量和最大自主通气量存在显著差异。此外,相关性分析发现 MG 患者 miR-146a 和 TRAFmRNA 表达呈正相关。多因素分析显示,miR-146a 和 TRAF6mRNA 是独立的 MG 发病因素,ROC 曲线分析结果显示 miR-146a 和 TRAF6mRNA 在 MG 诊断中的 AUC 分别为 0.782 和 0.703。

结论

miR-146a 和 TRAF6mRNA 在 MG 患者中高表达,可影响 MG 的发生。miR-146a 是诊断 MG 的一个合适的候选标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f425/8081603/39b7249b18e8/BMRI2021-5573469.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f425/8081603/e39764589dfa/BMRI2021-5573469.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f425/8081603/39b7249b18e8/BMRI2021-5573469.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f425/8081603/e39764589dfa/BMRI2021-5573469.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f425/8081603/39b7249b18e8/BMRI2021-5573469.002.jpg

相似文献

1
Expression and Clinical Significance of miR-146a and Tumor Necrosis Factor Receptor-Associated Factor 6 (TRAF6) in Myasthenia Gravis Patient Serum.miR-146a 和肿瘤坏死因子受体相关因子 6(TRAF6)在重症肌无力患者血清中的表达及临床意义。
Biomed Res Int. 2021 Apr 20;2021:5573469. doi: 10.1155/2021/5573469. eCollection 2021.
2
miR-146a in Myasthenia Gravis Thymus Bridges Innate Immunity With Autoimmunity and Is Linked to Therapeutic Effects of Corticosteroids.miR-146a 在重症肌无力胸腺瘤中连接先天免疫与自身免疫,并与皮质类固醇的治疗效果相关联。
Front Immunol. 2020 Mar 10;11:142. doi: 10.3389/fimmu.2020.00142. eCollection 2020.
3
MicroRNA-146a Ameliorates Inflammation via TRAF6/NF-κB Pathway in Intervertebral Disc Cells.微小RNA-146a通过椎间盘细胞中的TRAF6/NF-κB途径减轻炎症
Med Sci Monit. 2017 Feb 5;23:659-664. doi: 10.12659/msm.898660.
4
Effects of microRNA-146a on the proliferation and apoptosis of human osteoarthritis chondrocytes by targeting through the NF-κB signalling pathway.微小RNA-146a通过靶向NF-κB信号通路对人骨关节炎软骨细胞增殖和凋亡的影响
Biosci Rep. 2017 Apr 28;37(2). doi: 10.1042/BSR20160578. Print 2017 Apr 30.
5
Functional analysis of a panel of molecular markers for diagnosis of systemic lupus erythematosus in rats.用于系统性红斑狼疮大鼠诊断的分子标志物组合的功能分析。
Biosci Rep. 2024 Jul 31;44(7). doi: 10.1042/BSR20240318.
6
Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients.类风湿关节炎患者外周血单个核细胞中miR-146a表达上调。
Arthritis Res Ther. 2008;10(4):R101. doi: 10.1186/ar2493. Epub 2008 Aug 29.
7
Dysregulation of miRNA-146a contributes to the development of lupus nephritis via targeting of TRAF6.miRNA - 146a的失调通过靶向TRAF6促进狼疮性肾炎的发展。
Per Med. 2017 Mar;14(2):131-139. doi: 10.2217/pme-2016-0065. Epub 2017 Jan 24.
8
Regulation of MiR-146a and TRAF6 in the Diagnose of Lupus Nephritis.MiR-146a和TRAF6在狼疮性肾炎诊断中的调控作用
Med Sci Monit. 2017 May 26;23:2550-2557. doi: 10.12659/msm.900667.
9
MiR-146a Regulates Inflammatory Infiltration by Macrophages in Polymyositis/Dermatomyositis by Targeting TRAF6 and Affecting IL-17/ICAM-1 Pathway.微小RNA-146a通过靶向肿瘤坏死因子受体相关因子6并影响白细胞介素-17/细胞间黏附分子-1通路来调节巨噬细胞在多发性肌炎/皮肌炎中的炎性浸润
Cell Physiol Biochem. 2016;40(3-4):486-498. doi: 10.1159/000452563. Epub 2016 Nov 25.
10
A preliminary integrated analysis of miRNA-mRNA expression profiles reveals a role of miR-146a-3p/TRAF6 in plasma from gestational diabetes mellitus patients.对miRNA-mRNA表达谱的初步综合分析揭示了miR-146a-3p/TRAF6在妊娠期糖尿病患者血浆中的作用。
Ginekol Pol. 2024;95(8):627-635. doi: 10.5603/GP.a2023.0017. Epub 2023 Mar 17.

引用本文的文献

1
The intricate dance of non-coding RNAs in myasthenia gravis pathogenesis and treatment.非编码 RNA 在重症肌无力发病机制和治疗中的复杂作用。
Front Immunol. 2024 Mar 27;15:1342213. doi: 10.3389/fimmu.2024.1342213. eCollection 2024.
2
Defective autophagy and autophagy activators in myasthenia gravis: a rare entity and unusual scenario.重症肌无力中的自噬缺陷和自噬激活物:一种罕见的实体和不常见的情况。
Autophagy. 2024 Jul;20(7):1473-1482. doi: 10.1080/15548627.2024.2315893. Epub 2024 Mar 6.
3
Retracted: Expression and Clinical Significance of miR-146a and Tumor Necrosis Factor Receptor-Associated Factor 6 (TRAF6) in Myasthenia Gravis Patient Serum.

本文引用的文献

1
Role of miRNAs in Normal and Myasthenia Gravis Thymus.miRNAs 在正常和重症肌无力胸腺中的作用。
Front Immunol. 2020 Jun 10;11:1074. doi: 10.3389/fimmu.2020.01074. eCollection 2020.
2
miR-146a in Myasthenia Gravis Thymus Bridges Innate Immunity With Autoimmunity and Is Linked to Therapeutic Effects of Corticosteroids.miR-146a 在重症肌无力胸腺瘤中连接先天免疫与自身免疫,并与皮质类固醇的治疗效果相关联。
Front Immunol. 2020 Mar 10;11:142. doi: 10.3389/fimmu.2020.00142. eCollection 2020.
3
Myasthenia gravis.重症肌无力。
撤回:重症肌无力患者血清中miR-146a与肿瘤坏死因子受体相关因子6(TRAF6)的表达及临床意义
Biomed Res Int. 2024 Jan 9;2024:9754648. doi: 10.1155/2024/9754648. eCollection 2024.
4
Expression of TRAF6 in peripheral blood B cells of patients with myasthenia gravis.重症肌无力患者外周血 B 细胞中 TRAF6 的表达。
BMC Neurol. 2022 Aug 17;22(1):302. doi: 10.1186/s12883-022-02833-9.
5
miR-181a Ameliorates the Progression of Myasthenia Gravis by Regulating TRIM9.微小RNA-181a通过调控TRIM9改善重症肌无力的病情进展。
Evid Based Complement Alternat Med. 2021 Dec 9;2021:1303375. doi: 10.1155/2021/1303375. eCollection 2021.
6
A Review on the Role of Non-Coding RNAs in the Pathogenesis of Myasthenia Gravis.非编码 RNA 在重症肌无力发病机制中的作用研究进展
Int J Mol Sci. 2021 Nov 30;22(23):12964. doi: 10.3390/ijms222312964.
Nat Rev Dis Primers. 2019 May 2;5(1):30. doi: 10.1038/s41572-019-0079-y.
4
Roles of TRAF6 in Central Nervous System.TRAF6 在中枢神经系统中的作用。
Curr Neuropharmacol. 2018;16(9):1306-1313. doi: 10.2174/1570159X16666180412094655.
5
Evidence that miR-146a attenuates aging- and trauma-induced osteoarthritis by inhibiting Notch1, IL-6, and IL-1 mediated catabolism.miR-146a 通过抑制 Notch1、IL-6 和 IL-1 介导的分解代谢来减轻衰老和创伤引起的骨关节炎的证据。
Aging Cell. 2018 Jun;17(3):e12752. doi: 10.1111/acel.12752. Epub 2018 Mar 24.
6
Clinical Characteristics of Juvenile Myasthenia Gravis in Southern China.中国南方青少年型重症肌无力的临床特征
Front Neurol. 2018 Feb 27;9:77. doi: 10.3389/fneur.2018.00077. eCollection 2018.
7
Silencing miR-146a influences B cells and ameliorates experimental autoimmune myasthenia gravis.沉默miR-146a影响B细胞并改善实验性自身免疫性重症肌无力。
Immunology. 2015 Jan;144(1):56-67. doi: 10.1111/imm.12347.
8
Inhibition of miR-146a prevents enterovirus-induced death by restoring the production of type I interferon.抑制 miR-146a 通过恢复 I 型干扰素的产生来预防肠道病毒诱导的死亡。
Nat Commun. 2014;5:3344. doi: 10.1038/ncomms4344.
9
Altered expression of miR-146a in myasthenia gravis.miR-146a 在重症肌无力中的表达改变。
Neurosci Lett. 2013 Oct 25;555:85-90. doi: 10.1016/j.neulet.2013.09.014. Epub 2013 Sep 13.
10
TRAF6 directs commitment to regulatory T cells in thymocytes.TRAF6 指导胸腺细胞中调节性 T 细胞的分化。
Genes Cells. 2011 Apr;16(4):437-47. doi: 10.1111/j.1365-2443.2011.01500.x. Epub 2011 Mar 15.